The Antiviral Drugs Market is expected to register a CAGR of 2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antiviral Drugs Market report covers segmental analysis by Mechanism of Action (Protease Inhibitors, Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Others); Application (Hepatitis, HIV, Influenza, Herpes, Coronavirus Infection, Others); Type (Branded, Generic); Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries
Purpose of the ReportThe report Antiviral Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antiviral Drugs Market Segmentation
Mechanism of Action- Protease Inhibitors
- Nucleotide Polymerase Inhibitor
- Reverse Transcriptase Inhibitors
- Hepatitis
- HIV
- Influenza
- Herpes
- Coronavirus Infection
- Branded
- Generic
- Hospitals
- Retail Pharmacies
- Online Pharmacies
Strategic Insights
Antiviral Drugs Market Growth Drivers- Personalized Antiviral Therapies: The move toward personalized medicine is expected to significantly influence the antiviral drugs market. Advances in genomics and molecular profiling will enable healthcare providers to offer tailored antiviral treatments based on individual genetic makeup and viral strain characteristics. Personalized antiviral drugs will not only improve therapeutic outcomes but also minimize adverse effects, creating a demand for customized antiviral therapies. This trend aligns with the growing emphasis on precision medicine and is expected to revolutionize the way viral infections are treated in the future.
- Development of Broad-Spectrum Antiviral Drugs: The market for antiviral drugs is expected to see a surge in demand for broad-spectrum antiviral agents, which can target a wide range of viral pathogens, rather than just one specific virus. With the rise of new and evolving viral threats, such as novel coronaviruses and resistant strains of influenza, there is an increasing need for antiviral drugs that can provide protection against multiple viruses. The ability to address diverse viral infections with a single therapy will be a major focus for pharmaceutical companies, significantly impacting the antiviral drugs market in the coming years.
- Expansion of Over-the-Counter (OTC) Antiviral Drugs: The future antiviral drugs market will likely see an expansion in the availability of over-the-counter (OTC) antiviral medications. As consumers become more proactive about managing their health, the demand for easily accessible, self-administered antiviral treatments is expected to rise. OTC antiviral drugs, particularly for common viral infections like the flu or cold sores, will play a significant role in the future of the market. The growing shift toward at-home healthcare, spurred by the COVID-19 pandemic, will drive the demand for OTC antiviral drugs globally.
- Personalized Antiviral Therapies: The move toward personalized medicine is expected to significantly influence the antiviral drugs market. Advances in genomics and molecular profiling will enable healthcare providers to offer tailored antiviral treatments based on individual genetic makeup and viral strain characteristics. Personalized antiviral drugs will not only improve therapeutic outcomes but also minimize adverse effects, creating a demand for customized antiviral therapies. This trend aligns with the growing emphasis on precision medicine and is expected to revolutionize the way viral infections are treated in the future.
- Development of Broad-Spectrum Antiviral Drugs: The market for antiviral drugs is expected to see a surge in demand for broad-spectrum antiviral agents, which can target a wide range of viral pathogens, rather than just one specific virus. With the rise of new and evolving viral threats, such as novel coronaviruses and resistant strains of influenza, there is an increasing need for antiviral drugs that can provide protection against multiple viruses. The ability to address diverse viral infections with a single therapy will be a major focus for pharmaceutical companies, significantly impacting the antiviral drugs market in the coming years.
- Expansion of Over-the-Counter (OTC) Antiviral Drugs: The future antiviral drugs market will likely see an expansion in the availability of over-the-counter (OTC) antiviral medications. As consumers become more proactive about managing their health, the demand for easily accessible, self-administered antiviral treatments is expected to rise. OTC antiviral drugs, particularly for common viral infections like the flu or cold sores, will play a significant role in the future of the market. The growing shift toward at-home healthcare, spurred by the COVID-19 pandemic, will drive the demand for OTC antiviral drugs globally.
- Increase in Global Travel and Tourism: The growth of global travel and tourism presents an opportunity for the antiviral drugs market, as travel increases the risk of viral infections spreading across borders. The need for antiviral treatments, vaccines, and preventive medications is likely to grow as travelers are exposed to different viral strains. Public health initiatives and travel-related antiviral solutions, such as pre-exposure prophylactic treatments for viral diseases like malaria or influenza, can capitalize on this growing demand in the market.
- Rising Focus on Viral Resistance and New Drug Development: The increasing issue of viral resistance to current antiviral therapies offers a unique opportunity for the antiviral drugs market. Resistance has become a significant challenge, particularly in the treatment of HIV, hepatitis C, and influenza. Developing novel antiviral drugs that can overcome resistance or target multiple stages of viral replication can provide pharmaceutical companies with a competitive advantage. As healthcare providers search for more effective treatments to address resistant strains, there is a growing need for next-generation antiviral drugs, driving market growth.
- Growing Demand for Over-the-Counter (OTC) Antiviral Products: There is a rising consumer trend toward self-medication and greater access to healthcare products, providing an opportunity for the antiviral drugs market to expand through over-the-counter (OTC) offerings. The availability of OTC antiviral drugs for common conditions like the flu, cold sores, or even recurrent viral infections offers convenience and accessibility to consumers. Pharmaceutical companies can tap into this market by developing safe, effective, and affordable OTC antiviral products that allow consumers to manage minor viral infections without a prescription.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antiviral Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antiviral Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antiviral Drugs Market is expected to register a CAGR of 2% from 2025-2031.
The major factors impacting the Antiviral Drugs Market are: Personalized Antiviral Therapies, Development of Broad-Spectrum Antiviral Drugsand Expansion of Over-the-Counter (OTC) Antiviral Drugs
Key future trends in this market are - Personalized Antiviral Therapies, Development of Broad-Spectrum Antiviral Drugs and Expansion of Over-the-Counter (OTC) Antiviral Drugs
Key companies of this market are: F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck Sharp and Dohme Corp, Gilead Sciences, Inc, Bristol-Myers Squibb Company, Johnson and Johnson Services, Inc., Mylan N.V (Viatris), Dr. Reddy's Laboratories Ltd, Cipla Inc and Aurobindo Pharma USA
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiviral Drugs Market - By Mechanism of Action
1.3.2 Antiviral Drugs Market - By Application
1.3.3 Antiviral Drugs Market - By Type
1.3.4 Antiviral Drugs Market - By Distribution Channel
1.3.5 Antiviral Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIVIRAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - MECHANISM OF ACTION
7.1. OVERVIEW
7.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
7.3. PROTEASE INHIBITORS
7.3.1. Overview
7.3.2. Protease Inhibitors Market Forecast and Analysis
7.4. NUCLEOTIDE POLYMERASE INHIBITOR
7.4.1. Overview
7.4.2. Nucleotide Polymerase Inhibitor Market Forecast and Analysis
7.5. REVERSE TRANSCRIPTASE INHIBITORS
7.5.1. Overview
7.5.2. Reverse Transcriptase Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEPATITIS
8.3.1. Overview
8.3.2. Hepatitis Market Forecast and Analysis
8.4. HIV
8.4.1. Overview
8.4.2. HIV Market Forecast and Analysis
8.5. INFLUENZA
8.5.1. Overview
8.5.2. Influenza Market Forecast and Analysis
8.6. HERPES
8.6.1. Overview
8.6.2. Herpes Market Forecast and Analysis
8.7. CORONAVIRUS INFECTION
8.7.1. Overview
8.7.2. Coronavirus Infection Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
9.1. OVERVIEW
9.2. TYPE MARKET FORECASTS AND ANALYSIS
9.3. BRANDED
9.3.1. Overview
9.3.2. Branded Market Forecast and Analysis
9.4. GENERIC
9.4.1. Overview
9.4.2. Generic Market Forecast and Analysis
10. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antiviral Drugs Market Overview
11.1.2 North America Antiviral Drugs Market Forecasts and Analysis
11.1.3 North America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
11.1.4 North America Antiviral Drugs Market Forecasts and Analysis - By Application
11.1.5 North America Antiviral Drugs Market Forecasts and Analysis - By Type
11.1.6 North America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Antiviral Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antiviral Drugs Market
11.1.7.1.1 United States Antiviral Drugs Market by Mechanism of Action
11.1.7.1.2 United States Antiviral Drugs Market by Application
11.1.7.1.3 United States Antiviral Drugs Market by Type
11.1.7.1.4 United States Antiviral Drugs Market by Distribution Channel
11.1.7.2 Canada Antiviral Drugs Market
11.1.7.2.1 Canada Antiviral Drugs Market by Mechanism of Action
11.1.7.2.2 Canada Antiviral Drugs Market by Application
11.1.7.2.3 Canada Antiviral Drugs Market by Type
11.1.7.2.4 Canada Antiviral Drugs Market by Distribution Channel
11.1.7.3 Mexico Antiviral Drugs Market
11.1.7.3.1 Mexico Antiviral Drugs Market by Mechanism of Action
11.1.7.3.2 Mexico Antiviral Drugs Market by Application
11.1.7.3.3 Mexico Antiviral Drugs Market by Type
11.1.7.3.4 Mexico Antiviral Drugs Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Antiviral Drugs Market Overview
11.2.2 Europe Antiviral Drugs Market Forecasts and Analysis
11.2.3 Europe Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
11.2.4 Europe Antiviral Drugs Market Forecasts and Analysis - By Application
11.2.5 Europe Antiviral Drugs Market Forecasts and Analysis - By Type
11.2.6 Europe Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Antiviral Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antiviral Drugs Market
11.2.7.1.1 Germany Antiviral Drugs Market by Mechanism of Action
11.2.7.1.2 Germany Antiviral Drugs Market by Application
11.2.7.1.3 Germany Antiviral Drugs Market by Type
11.2.7.1.4 Germany Antiviral Drugs Market by Distribution Channel
11.2.7.2 France Antiviral Drugs Market
11.2.7.2.1 France Antiviral Drugs Market by Mechanism of Action
11.2.7.2.2 France Antiviral Drugs Market by Application
11.2.7.2.3 France Antiviral Drugs Market by Type
11.2.7.2.4 France Antiviral Drugs Market by Distribution Channel
11.2.7.3 Italy Antiviral Drugs Market
11.2.7.3.1 Italy Antiviral Drugs Market by Mechanism of Action
11.2.7.3.2 Italy Antiviral Drugs Market by Application
11.2.7.3.3 Italy Antiviral Drugs Market by Type
11.2.7.3.4 Italy Antiviral Drugs Market by Distribution Channel
11.2.7.4 Spain Antiviral Drugs Market
11.2.7.4.1 Spain Antiviral Drugs Market by Mechanism of Action
11.2.7.4.2 Spain Antiviral Drugs Market by Application
11.2.7.4.3 Spain Antiviral Drugs Market by Type
11.2.7.4.4 Spain Antiviral Drugs Market by Distribution Channel
11.2.7.5 United Kingdom Antiviral Drugs Market
11.2.7.5.1 United Kingdom Antiviral Drugs Market by Mechanism of Action
11.2.7.5.2 United Kingdom Antiviral Drugs Market by Application
11.2.7.5.3 United Kingdom Antiviral Drugs Market by Type
11.2.7.5.4 United Kingdom Antiviral Drugs Market by Distribution Channel
11.2.7.6 Rest of Europe Antiviral Drugs Market
11.2.7.6.1 Rest of Europe Antiviral Drugs Market by Mechanism of Action
11.2.7.6.2 Rest of Europe Antiviral Drugs Market by Application
11.2.7.6.3 Rest of Europe Antiviral Drugs Market by Type
11.2.7.6.4 Rest of Europe Antiviral Drugs Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antiviral Drugs Market Overview
11.3.2 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
11.3.4 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Type
11.3.6 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antiviral Drugs Market
11.3.7.1.1 Australia Antiviral Drugs Market by Mechanism of Action
11.3.7.1.2 Australia Antiviral Drugs Market by Application
11.3.7.1.3 Australia Antiviral Drugs Market by Type
11.3.7.1.4 Australia Antiviral Drugs Market by Distribution Channel
11.3.7.2 China Antiviral Drugs Market
11.3.7.2.1 China Antiviral Drugs Market by Mechanism of Action
11.3.7.2.2 China Antiviral Drugs Market by Application
11.3.7.2.3 China Antiviral Drugs Market by Type
11.3.7.2.4 China Antiviral Drugs Market by Distribution Channel
11.3.7.3 India Antiviral Drugs Market
11.3.7.3.1 India Antiviral Drugs Market by Mechanism of Action
11.3.7.3.2 India Antiviral Drugs Market by Application
11.3.7.3.3 India Antiviral Drugs Market by Type
11.3.7.3.4 India Antiviral Drugs Market by Distribution Channel
11.3.7.4 Japan Antiviral Drugs Market
11.3.7.4.1 Japan Antiviral Drugs Market by Mechanism of Action
11.3.7.4.2 Japan Antiviral Drugs Market by Application
11.3.7.4.3 Japan Antiviral Drugs Market by Type
11.3.7.4.4 Japan Antiviral Drugs Market by Distribution Channel
11.3.7.5 South Korea Antiviral Drugs Market
11.3.7.5.1 South Korea Antiviral Drugs Market by Mechanism of Action
11.3.7.5.2 South Korea Antiviral Drugs Market by Application
11.3.7.5.3 South Korea Antiviral Drugs Market by Type
11.3.7.5.4 South Korea Antiviral Drugs Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Antiviral Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Antiviral Drugs Market by Mechanism of Action
11.3.7.6.2 Rest of Asia-Pacific Antiviral Drugs Market by Application
11.3.7.6.3 Rest of Asia-Pacific Antiviral Drugs Market by Type
11.3.7.6.4 Rest of Asia-Pacific Antiviral Drugs Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antiviral Drugs Market Overview
11.4.2 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
11.4.4 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Type
11.4.6 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antiviral Drugs Market
11.4.7.1.1 South Africa Antiviral Drugs Market by Mechanism of Action
11.4.7.1.2 South Africa Antiviral Drugs Market by Application
11.4.7.1.3 South Africa Antiviral Drugs Market by Type
11.4.7.1.4 South Africa Antiviral Drugs Market by Distribution Channel
11.4.7.2 Saudi Arabia Antiviral Drugs Market
11.4.7.2.1 Saudi Arabia Antiviral Drugs Market by Mechanism of Action
11.4.7.2.2 Saudi Arabia Antiviral Drugs Market by Application
11.4.7.2.3 Saudi Arabia Antiviral Drugs Market by Type
11.4.7.2.4 Saudi Arabia Antiviral Drugs Market by Distribution Channel
11.4.7.3 U.A.E Antiviral Drugs Market
11.4.7.3.1 U.A.E Antiviral Drugs Market by Mechanism of Action
11.4.7.3.2 U.A.E Antiviral Drugs Market by Application
11.4.7.3.3 U.A.E Antiviral Drugs Market by Type
11.4.7.3.4 U.A.E Antiviral Drugs Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Antiviral Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Antiviral Drugs Market by Mechanism of Action
11.4.7.4.2 Rest of Middle East and Africa Antiviral Drugs Market by Application
11.4.7.4.3 Rest of Middle East and Africa Antiviral Drugs Market by Type
11.4.7.4.4 Rest of Middle East and Africa Antiviral Drugs Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antiviral Drugs Market Overview
11.5.2 South and Central America Antiviral Drugs Market Forecasts and Analysis
11.5.3 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
11.5.4 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Application
11.5.5 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Type
11.5.6 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antiviral Drugs Market
11.5.7.1.1 Brazil Antiviral Drugs Market by Mechanism of Action
11.5.7.1.2 Brazil Antiviral Drugs Market by Application
11.5.7.1.3 Brazil Antiviral Drugs Market by Type
11.5.7.1.4 Brazil Antiviral Drugs Market by Distribution Channel
11.5.7.2 Argentina Antiviral Drugs Market
11.5.7.2.1 Argentina Antiviral Drugs Market by Mechanism of Action
11.5.7.2.2 Argentina Antiviral Drugs Market by Application
11.5.7.2.3 Argentina Antiviral Drugs Market by Type
11.5.7.2.4 Argentina Antiviral Drugs Market by Distribution Channel
11.5.7.3 Rest of South and Central America Antiviral Drugs Market
11.5.7.3.1 Rest of South and Central America Antiviral Drugs Market by Mechanism of Action
11.5.7.3.2 Rest of South and Central America Antiviral Drugs Market by Application
11.5.7.3.3 Rest of South and Central America Antiviral Drugs Market by Type
11.5.7.3.4 Rest of South and Central America Antiviral Drugs Market by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
13.1. F. HOFFMANN-LA ROCHE LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MERCK SHARP AND DOHME CORP
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GILEAD SCIENCES, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BRISTOL-MYERS SQUIBB COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JOHNSON AND JOHNSON SERVICES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MYLAN N.V (VIATRIS)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DR. REDDY'S LABORATORIES LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CIPLA INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AUROBINDO PHARMA USA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Merck Sharp and Dohme Corp
- Gilead Sciences, Inc
- Bristol-Myers Squibb Company
- Johnson and Johnson Services, Inc.
- Mylan N.V (Viatris)
- Dr. Reddy's Laboratories Ltd
- Cipla Inc
- Aurobindo Pharma USA
- Glenmark
- Genentech
- Abbott
- Himalaya Wellness Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For